Product IntroductionBioactivity英文名:
AZ191描述: AZ191 是特异性 DYRK1B 抑制剂。它对 DYRK1B 的特异性分别是 DYRK1A 和 DYRK2 的 5 倍和 110 倍。
激酶实验: Biochemical Binding Affinity – HTRF Assay: The p53-MDM2 HTRF assay is performed in buffer containing 50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 1 mM DTT, 0.02 or 0.2 mg/ml BSA. Small-molecule inhibitors are stored in aliquots as 10 mM stock solutions in DMSO at 4°C in 96-deep-well plates. It is thawed and mixed immediately prior to testing. The compound is incubated with GST-MDM2 and a biotinylated p53 peptide for one hour at 37°C. Phycolink goat anti-GST (Type 1) allophycocyanin and Eu-8044-streptavidin are then added and followed by one hour incubation at room temperature. Plates are read using the Envision fluorescence reader. IC50 values are determined from inter-plate duplicate or triplicate sets of data. Data are analyzed by XLfit4 (Microsoft) using a 4 Parameter Logistic Model (Sigmoidal Dose-Response Model) and the equation Y= (A+ ((B-A)/ (1+ ((C/x)^D)))), where A and B are enzyme activity in the absence or presence of infinite inhibitor compound, respectively, C is the IC50 and D is the Hill coefficient.
体外活性: AZ191 selectively inhibits DYRK1B serine/threonine kinase activity with no effect on tyrosine kinase autophosphorylation. In HEK-293 cells, AZ191 also displays much greater potency for DYRK1B over DYRK1A, inhibiting CCND1 phosphorylation. In HD1B cells, AZ191 strongly inhibits the levels of the cell-cycle regulators, p21Cip1 and p27Kip1, and increases cell-cycle progression. [1]
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: H2O : < 1 mg/mL (insoluble or slightly soluble)
Ethanol : 1 mg/mL (2.32 mM)
DMSO : 79 mg/mL (183.9 mM)
关键字:
Inhibitor |
Dual specificity tyrosine regulated kinase |
Dual specificity tyrosine phosphorylation regulated kinase |
inhibit |
AZ191 |
DYRK |
AZ 191 |
AZ-191相关产品:
Harmine |
LDN-192960 |
ML167 |
GNF4877 |
DYRKs-IN-2 |
AnnH31 |
GSK-626616 |
INDY |
ARN25068 |
CK2/ERK8-IN-1相关库:
Cell Cycle Compound Library |
Anti-Cancer Compound Library |
Bioactive Compounds Library Max |
Inhibitor Library |
Kinase Inhibitor Library |
Tyrosine Kinase Inhibitor Library |
Target-Focused Phenotypic Screening Library |
NO PAINS Compound Library |
Bioactive Compound Library